Efficient variable selection in high dimensional cancer genomic studies is critical for discovering genes associated with specific cancer types and for predicting response to treatment. Censored survival data is prevalent in such studies. In this article we introduce a Bayesian variable selection procedure that uses a mixture prior composed of a point mass at zero and an inverse moment prior in conjunction with the partial likelihood defined by the Cox proportional hazard model. The procedure is implemented in the R package BVSNLP, which supports parallel computing and uses a stochastic search method to explore the model space. Bayesian model averaging is used for prediction. The proposed algorithm provides better performance than other variable selection procedures in simulation studies, and appears to provide more consistent variable selection when applied to actual genomic datasets.
Introduction
Recent developments in sequencing technology have made it easier to collect massive genomic datasets that can be used to study cancer and other diseases. Given such data, there is great interest in linking genomic data to patient outcomes, and in many cases such outcomes are censored survival times.
Survival times for patients generally represent either the time to death or disease progression, the time to study termination, or the time until the subject is lost to follow up. In the latter cases, the subject's survival time is censored. The relation between survival times and covariates is modeled through the conditional hazard function, which is the limiting probability of death in the interval (t, t + ∆t) as ∆t becomes small, given patient covariates. More precisely, the hazard function h for patient i may be defined as h(t|x i ) = lim
where x i is a p vector of covariates thought to influence survival. We denote by X the n × p design matrix obtained by stacking n patient covariate vectors. Proportional hazard models take the form h(t | x i ) = h 0 (t)Φ(x i ).
with an identifiability constraint of Φ(0) = 1. In this formula, h 0 (t) denotes the baseline hazard function. The Cox proportional hazards model (Cox, 1972 ) is defined by taking Φ(x i ) = exp{x T i β}, leading to h(t | x i ) = h 0 (t)e
Here, β is a p × 1 vector of coefficients. An important feature of the proportional hazards model is that it yields a partial likelihood function that is independent of the baseline hazard function, h 0 . For complete survival analyses, however, the baseline hazard function is necessary for predicting survival times and can be estimated non-parametrically. Further details regarding the Cox proportional hazard model may be found in Cox and Oakes (1984) , Kalbfleisch and Prentice (1980) or Cox (1972) .
Gene expression datasets usually contain measurements on thousands of genes collected for only hundreds of subjects. Biologically it seems plausible that only a relatively small number of these genes contribute significantly to survival. This implies that most of the elements in the vector β are small or are close to zero. The challenge is to find covariates with non-zero coefficients or, equivalently, those genes that contribute the most in determining the survival outcome.
Many common penalized likelihood methods originally introduced for linear regression have been extended to survival data. These methods include LASSO (Tibshirani et al., 1997) , where an L 1 penalty is imposed on regression coefficients. Zhang and Lu (2007) utilized adaptive LASSO methodology for time to event data, while Antoniadis et al. (2010) adopted the Dantzig selector for survival outcomes. The extension of non-convex penalized likelihood approaches, in particular SCAD, to the Cox proportional hazard model is discussed in Fan and Li (2002) . The ISIS approach is also extended for ultrahigh dimensional survival data in Fan et al. (2010) , where it is used on Cox proportional hazard models and the SCAD penalty is employed for variable selection.
Some Bayesian approaches have also been proposed. Faraggi and Simon (1998) proposed a method based on approximating the posterior distribution of the parameters in the proportional hazard model by defining a Gaussian prior on regression coefficients. A loss function was then imposed to select a parsimonious model. A semi-parametric Bayesian approach was utilized by Ibrahim et al. (1999) , who employed a discrete gamma process for the baseline hazard function and a multivariate Gaussian prior for the coefficient vector. Sha et al. (2006) considered Accelerated Failure Time (AFT) models along with data augmentation to impute failure times. A mixture prior proposed by George and McCulloch (1997) was used to impose sparsity. In more recent work, Held et al. (2016) proposed the use of a g-prior model for the coefficient vector and employed test-based Bayes factors (Johnson, 2005) to the Cox proportional hazard models. However, this method is intended for use only when the number of covariates is less than the number of observations, p < n.
To our knowledge, all previous Bayesian procedures for variable selection in survival data have used local priors on model coefficients. In this article, we propose a Bayesian method based on a mixture prior comprised of a point mass at zero and a nonlocal prior on the regression coefficients. To handle the computational burden of implementing the resulting procedure we employ a stochastic search method, S5 (Shin et al., 2018) , which we implement in an R package BVSNLP. We also discuss a general procedure for setting the tuning parameter of the nonlocal prior.
This article is structured as follows. In Section 2 we introduce notation, and discuss the methodology behind our proposed method. Section 3 provides simulation and real data analyses to illustrate the performance of the proposed method, and compares it to several competing methods. Section 4 concludes with discussion.
Methods

Preliminaries
Let T i denote the survival time and C i denote the censoring time for individual i. Each element in the observed vector of survival times, y, is defined as y i = min{T i , C i }. The status for each individual is defined as δ i = I(T i ≤ C i ). The status vector is represented by δ = (δ 1 , δ 2 , . . . , δ n )
T . We assume that the censoring mechanism is at random, meaning that C i and T i are conditionally independent given x i , where x i ∈ R p are the covariates for individual i and comprise the i th row of X. The observed data is of the form (y i , δ i , x i ); i = 1, 2, . . . , n .
Model k is defined as k = {k 1 , . . . , k j } where (1 ≤ k 1 < · · · < k j ≤ p) and it is assumed that β k 1 = 0, . . . , β k j = 0 and all other elements of β are 0. The design matrix corresponding to model k is denoted by X k , and the regression vector by
T . Let R(t) = {i : y i ≤ t} represent the risk set at time t, the set of all individuals who are still present in the study at time t and are neither dead nor censored. We assume throughout this article that the failure times are distinct. In other words, only one individual fails at a specific failure time. With this assumption and letting ξ ki = exp{x (Cox, 1972) for β k in model k can be written as
Our method uses this partial likelihood as the sampling distribution in our Bayesian model selection procedure. We acknowledge that there is some information loss in (4) with respect to β k . For instance, Basu (Ghosh, 1988) argues that partial likelihoods can not usually be interpreted as sampling distributions. On the other hand, Berger et al. (1999) encourage the use of partial likelihoods when the nuisance parameters are marginalized out.
Sorting the observed unique survival times in ascending order and consequently reordering the status vector δ as well as the design matrix X with respect to the ordered y, the sampling distribution of y for model k can be written as
A Bayesian hierarchical model can be defined in which π(y | β k ) in (5) represents the sampling distribution, π k (β k ) is the prior of model coefficients β k , and p(k) is the prior for model k. Using Bayes rule, the posterior probability for model j is written as
where J is the set of all possible models and the marginal probability of the data under model k is defined by
The prior density for β k and the prior on the model space impact the overall performance of the selection procedure and the amount of sparsity imposed on candidate models. Note that the sampling distribution in (5) is continuous in β k , and in Section 2.3 we define an inverse moment prior (Johnson and Rossell, 2010) on each of the coefficients in model k.
Prior on Model Space
Let γ k = {γ 1 , · · · , γ p } denote a binary vector indicating which covariates are included in model k. The nonzero indices of γ k represent the indices of the nonzero elements in the coefficient vector, β, which a priori are modeled as independent Bernoulli random variables with success probability P (γ i = 1) = θ for every 1 ≤ i ≤ p. As discussed in Scott et al. (2010) , no fixed value for θ adjusts for multiplicity. As a result, it is necessary to define a prior on θ, say π(θ). The resulting marginal probability for model k in a fully Bayesian approach may then be written as
A common choice for π(θ) is the beta distribution, θ ∼ Beta(a, b), where in the special case of a = b = 1, π(θ) is a uniform distribution. The marginal probability for model k derived from (8) is then equal to
where B(·) is the Beta function. By choosing a = p and b = p − a, the mean and variance of the selected model size k is
To incorporate the belief that the optimal predictive models are sparse, we recommend setting a = 1 and b = p − a. The resulting prior assigns comparatively small prior probabilities to models that contain many covariates.
Product Inverse MOMent (piMOM) Prior
We impose nonlocal prior densities on the non-zero coefficients, β k . Specifically, we assume the prior densities on the non-zero coefficients in model k take the form of a product of independent iMOM priors, or piMOM densities (Johnson and Rossell, 2012) , expressible as
The hyperparameter τ represents a scale parameter that determines the dispersion of the prior around 0, while r determines the tail behavior of the density. Unlike most penalized likelihood methods, large values of regression coefficients are not heavily penalized by this prior. As a result, it does not necessarily impose significant penalties on non-sparse models provided that the estimated coefficients in those models are not small.
Selection of Hyperparameters
We use the procedure described in Nikooienejad et al. (2016) to select hyperparameter values for the piMOM prior. In that method, the null distribution of the maximum likelihood estimator for β k (i.e., all components of β k are 0), obtained from randomly selected design matrices X k , is compared to the prior density on β k for various values of (r, τ ). Fixing r = 1 to achieve Cauchy-like tails, a value of τ is chosen so that the overlap between the two densities is less than a specified threshold, 1/ √ p, and is denoted by τ 1 . It can be shown that the maximum of the iMOM prior occurs at ± √ τ . We also allow users to input a prior parameter α that controls where the maximum modes in the prior occur. This can be useful in constraining the prior density when covariates are highly correlated (resulting in an over-dispersed prior when the sampling distribution of the null MLE under the null model becomes overly broad). We then set the value of τ according to
To implement the procedure of computing τ 1 for survival models, we generate response vectors under the null model using the procedure described by Bender et al. (2005) . Survival times are sampled from a standard exponential model.
Let t s and c s be the vector of sampled survival times and censoring times, respectively. The sampled survival time and status for each observation is then computed as
which comprise y s and δ s under the null model. Using the pair (y s , δ s ), the MLE from Cox model is computed. It should be noted that the asymptotic distribution of the MLE for the Cox model under the null hypothesis isβ ∼ N 0, I(β) , where I(β) is the information matrix of the partial likelihood function. Thus, it is appropriate to approximate the pooled estimated coefficients in that algorithm with a normal density function. When the sample size gets large, the variance of the MLE decreases and causes the overlap to become small and consequently small values of τ are selected.
In general, we find that r = 1 and τ = 0.25 are good default values if one chooses not to run the hyperparameter selection algorithm. When r = 1, the peaks of the iMOM prior occur at − √ τ and √ τ . By equating √ τ to the absolute value of the most common effect size for that application, it provides insight on what default value of τ would be for different applications. Further details regarding this algorithm can be found in Nikooienejad et al. (2016) .
Computing Posterior Probability of Models
Computing the posterior probability for each model requires the marginal probability of observed survival times under each model as shown in (6), (7). The marginal probability is approximated by using the Laplace approximation, where the regression coefficients in β k are integrated out. This leads to
Here,β k is the maximum a posteriori (MAP) estimate of β k , Gβ k is the Hessian of the negative of the log posterior function,
computed atβ k and k is the size of model k. Finding the MAP of β k is equivalent to finding the minimum of g(β k ).
Calculating the Gradient and Hessian of
. For a n × p matrix A, let A (i) denote the n × 1 vector corresponding to the i th column of A and A j denote the 1 × p vector corresponding to the j th row of A. Also let A i = (A i:n,. ) T , where A i:n,. is the sub-matrix of A from row i to the last row where all columns are included. This makes the dimension of A i equal to p × (n − i + 1). Similarly, for a vector α of size n, let α i denote the sub-vector of α components i, i + 1, . . . , n, a vector of size (n − i + 1).
T . Also let η denote the n × 1 column vector (5) can then be expressed as
For each n × k design matrix X k and β k vector, define a new k × n matrix X k , with i
Here, X ki and η i are obtained from matrix X k and vector η, respectively, using the notation described in the beginning of this section. The negative gradient of l(y; β k ) can then be written as
To compute the Hessian matrix, let X k ij be the (i, j) element of X k . The k × k identity matrix is denoted by I k and D(α) denotes a diagonal matrix with the elements of the vector α on its diagonal. Finally, let ζ j = X k(j) , the j th column of X k . Row j of the k × k Hessian matrix of −l(y; β k ) is defined as
The Ω j n×k matrix itself is constructed row by row, with row i equal to
Computing Hessian can be implemented with a computational complexity of O(n).
The gradient and Hessian of the logarithm of the piMOM prior is more straightforward, and is given by
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The Hessian of −l π (β k ) is a diagonal matrix, D(α), where
The gradient and Hessian matrix of g(β k ) are thus described by equations (18) to (22). These expressions are used to find the MAP, and to compute the Laplace approximation to the marginal probability of y.
We use the limited memory version of the Broyden-Fletcher-Goldfarb-Shanno optimization algorithm (L-BFGS) (Liu and Nocedal, 1989) to find the MAP. The initial value for the algorithm isβ k , the MLE for the Cox proportional hazard model.
Having all the components of formula (6), it is possible to define a MCMC framework to sample from the posterior distribution on the model space. A birth-death scheme, similar to that used in Nikooienejad et al. (2016) , can be exploited for this purpose. However, we use an alternative stochastic search based approach to search the model space that is discussed in the following section.
The highest posterior probability model (HPPM) is defined as the model having the highest posterior probability among all visited models. In practice, many models may be assigned probabilities that are close to the probability achieved by the HPPM. For this reason and for predictive purposes, it is useful to obtain the Median Probability Model (MPM) (Barbieri et al., 2004) , which is the model containing covariates that have posterior inclusion probabilities of at least 0.5. According to Barbieri et al. (2004) , the posterior inclusion probability for covariate i is defined as
That is, the sum of posterior probabilities of all models that have covariate i as one of their variables. In this expression, γ k i is a binary value determining the inclusion of the i th covariate in model k.
Stochastic Search Algorithm
To increase the efficiency of exploring the model space, we use the S5 technique. S5 was proposed by Shin et al. (2018) for variable selection in linear regression problems, and we adapt it here for the survival models. It is a stochastic search method that screens covariates at each step. The algorithm is scalable and its computational complexity is only linearly dependent on p (Shin et al., 2018) . Screening is the essential part of the S5 algorithm. In linear regression, screening is defined based on the correlation between remaining covariates and the residuals of the regression using the current model (Fan and Lv, 2008) . The concept of screening covariates for survival response data is proposed in Fan et al. (2010) , and is defined based on the marginal utility for each covariate.
To illustrate the screening technique, suppose that the current model is k. The condi-tional utility of covariate m ∈ k c is basically the amount of information it contributes to the survival outcome, given model k, and is defined as
By comparing u m | k to (16), it can be seen that the conditional utility is the maximum likelihood for covariate m after accounting for the information provided by model k. Finding u m | k is a univariate optimization procedure and thus is fast to compute. The S5 algorithm for survival data works as follows. At each step, the d covariates with highest conditional utility are candidates to be added to the current model k and comprise the addition set, Γ + . The deletion set, Γ − contains the current model, except that one variable is removed. From the current model, k, we consider moves to each of its neighbors in Γ + and Γ − with a probability proportional to the marginal probabilities of these neighboring models.
To avoid getting stuck in local maxima, the model probabilities used in S5 are raised to the power of 1/t i , where t i is the i th temperature in an annealing schedule in which "temperatures" decrease. To increase the number of visited models, a specified number of iterations are performed at each temperature. At the end of the procedure, the model with the highest posterior probability out of visited models is identified as the HPPM.
In our version of the S5 algorithm, we used 10 equally spaced temperatures varying from 3 to 1 and 30 iterations within each temperature. To increase the number of visited models, we parallelized the S5 procedure so that it could be distributed to multiple CPUs. Each CPU executes the S5 algorithm independently with a different starting model. All visited models are pooled together at the end and the HPPM and MPM are determined. Using posterior probabilities of the visited models, the posterior inclusion probability for each covariate can be computed using (23). In our simulations, we used 120 CPUs to explore the model space for design matrices with O(10 4 ) covariates.
Predictive Accuracy Assessment
In addition to looking at the selected genes and their pathways to determine their biological relevance, we used the time dependent AUC, obtained from time dependent ROC curves as introduced by Heagerty et al. (2000) for survival times to summarize and compare the predictive performance of the various algorithms. This measure has a relatively straightforward interpretation, and unlike other summary measures such as c-index (Harrell Jr et al., 1982) , can be computed without requiring specific conditions or additional assumptions to hold (Blanche et al., 2018) .
There are different methods to estimate time dependent sensitivity and specificity. In our algorithm, we adapted a method proposed by Uno et al. (2007) , henceforth called Uno's method. In that method, sensitivity is estimated by
and specificity is estimated by
These values are estimated for the test set. Therefore, in the equations above, n is the number of observations in the test set, δ i is the status of observation i and T i is the observed time for that observation in the test set. The variable c is the discrimination threshold that is varied to obtain the ROC curve. The functionĜ is the Kaplan-Meier estimate of the survival function obtained from the training set. For each observation i in the test set with observed time T i ,Ĝ(T i ) is computed by a basic interpolation procedure. That is,
Here, T tr is the set of all observed survival times in the training set. In (25) and (26),β represents the estimated coefficient under a specific model. This is where different models can play role in determining sensitivity and specificity.
Bayesian Model Averaging (BMA)
BMA can be used to improve the predictive accuracy by accounting for the uncertainty in selected models. From (25) and (26) the final sensitivity and specificity using BMA may be defined as
and
where, p(M k i | y n ) is the posterior probability of model M k i The value of N depends on what type of BMA is used. We use Occam's window, which means only models that have posterior probability of at least α × p(M HP P M | y n ) are used in model averaging. We set α = 0.01 for our applications.
Estimating Individual Survival Curves
In the Cox proportional hazard model the survival function for individual i under model M k is defined as
where H 0 (t; M k ) = t 0 h 0 (τ ; M k )dτ is the cumulative baseline hazard function, which can be estimated by
This is known as the Breslow estimator of H 0 (t; M k ) (the observed times are sorted as in (5)). At this point three approaches can be exploited to estimate the survival curve for individual i. The first approach is to compute the HPPM survival curve by replacing M k with M HP P M , and use the MAP estimate of β under the HPPM,β HP P M , in (30) and (31). That is,
The second approach is computationally more intensive but takes into account the uncertainty of the posterior samples of model space. In this approach, samples from the posterior distribution of the survival function are generated by replacing k in (30) with every posterior sample of the model space. The estimated survival curve is then obtained by taking the average of the posterior samples. That is,
where K is the number of posterior samples. The third approach is to use Bayesian model averaging. As discussed in the previous section, we use Occam's window where only the models with posterior probability of at least 0.01 × p(M HP P M |y n ) are used in model averaging. Suppose N models fall in Occam's window. Then
Similar approaches were also adopted by Held et al. (2016) in estimating the survival curve for each individual in a study.
Results
To investigate the performance of the proposed model selection procedure, we applied our method to simulated datasets and real cancer genomic data. For both simulation and real data, we compared the performance of our algorithm to ISIS-SCAD (Fan et al., 2010) and GLMNET (Friedman et al., 2010) . For real data, we considered two common cancer types from The Cancer Genome Atlas (TCGA) website: kidney renal clear cell carcinoma (KIRC) (Cancer Genome Atlas Research Network, 2013) and kidney renal papillary cell carcinoma (KIRP) (Cancer Genome Atlas Research Network, 2016). The details are discussed in the following sections.
Simulation Studies
We first examined the six simulation settings described in Fan et al. (2010) . These settings consider different aspects of variable selection with respect to the correlation between true covariates and the magnitude of true coefficients. Here, we report two of the hardest settings, which Fan et al. (2010) called equi-correlated covariates with correlation = 0.5 and two very hard variables to be selected. We refer to these settings as Case 1 and 2, respectively. We also added a third case in which the survival times are sampled from a Weibull distribution with uniform censoring. For Case 1, X 1 , . . . , X p are multivariate Gaussian random variables with mean 0 and marginal variance of 1. The correlation structure between variables is corr(X i , X j ) = 0.5. The size of the true model is six with non-zero regression coefficients β 1 = −1.5140, β 2 = 1.2799, β 3 = −1.5307, β 4 = 1.5164, β 5 = −1.3020, β 6 = 1.5833, and β i = 0 for i > 6. The number of observations and covariates are n = 400 and p = 1000. The censoring rate for this case is 23%.
For Case 2, X 1 , . . . , X p are multivariate Gaussian random variables with mean 0 and marginal variance of 1. The correlation structure is corr(X i , X 5 ) = 0 for all i = 5, corr(X i , X 4 ) = 1/ √ 2 for i ∈ {4, 5}, and corr(X i , X j ) = 0.5 for i, j ∈ {1, . . . , p} \ {4, 5}. The size of the true model is five with non-zero regression coefficients β 1 = 4, β 2 = 4, β 3 = 4, β 4 = −6 √ 2, β 5 = 4/3 and β i = 0 for i > 5. The censoring rate for this case is 38%. Similar to the previous case, the number of observations and covariates are n = 400 and p = 1000. In both Case 1 and Case2 the survival times and censoring times are sampled from an exponential distribution. The rate parameter for the distribution of censoring times is set to 0.1.
For Case 3, all of the parameters are the same as Case 1 except that the baseline hazard function was a Weibull distribution with rate parameter λ = 1 and the shape parameter k = 1.5. The censoring times were sampled uniformly from [0, 8] , and the resulting censoring rate for this case is 24%.
To measure the performance of the algorithms, we repeated each simulation setting 50 different times. Four different outcomes are reported. The first two outcomes are the mean l 1 norm and the mean l 2 norm for coefficient estimation error. The l 1 norm is computed as p i=1 |β i − β i |, and the l 2 norm is computed as
2 1/2 . The third outcome is the mean model size of the selected models in 50 different iterations and is denoted by MMS. MTP and MFP denote mean false positive and mean true positive values for each algorithm. The last outcome is the proportion of times that the algorithm selected the true model (without any false positives). This proportion is denoted by P . Table 1 shows the performance comparison between our method, BVSNLP, the default variant type of ISIS-SCAD and GLMNET algorithms. The λ parameter in GLMNET is picked by cross validation.
In the S5 algorithm, 30 iterations are used within each temperature. The parameter d was chosen as 2 log(p) . Each S5 algorithm was run in parallel on 120 CPUs for both simulation cases. The beta-binomial prior was imposed on the model space with average model size equal to 1. The hyperparameters were selected using the algorithm discussed in Section 2.3.1 with α = 0.8 imposed as the maximum prior modal. The value of α was the same in all three simulation cases. Finally, the average run-time of BVSNLP algorithm for the entire simulation over 50 simulations was 20.4 seconds for Case 1, 98.5 seconds for Case 2 and 20.0 seconds for Case 3 using 120 CPUs. As demonstrated in Table 1 , our method performs better than the other two methods. The BVSNLP algorithm chose the correct model with no false positives in all 50 iterations in all simulation scenarios.
Comparison With pMOM Prior
Another nonlocal prior that might be considered as a potential candidate for the prior densities on the non-zero coefficients in model k is the product of independent MOM priors, or pMOM densities (Johnson and Rossell, 2012) , specified by
The hyperparameter τ has the same role as in piMOM in (11) and r is the order of the density. Figure 1 depicts an example of iMOM and MOM priors for r = 1 and τ = 0.5. For r = 1 and a fixed τ , piMOM assigns zero probability to a wider region around zero than does the pMOM density. This potentially leads to smaller false positive rate in the selection procedure for piMOM by preventing variables with negligible coefficients to be selected. On the other hand, pMOM has tails that converge to zero at an exponential rate, while piMOM possesses Cauchy-like tails that allows it to better detect large coefficients. For these reasons, piMOM seems to be a better fit as a default choice of prior for non-zero coefficients in variable selection problems. The consistency properties of piMOM priors for linear models was studied in Shin et al. (2018) . There, it is shown that piMOM priors are consistent for p = O(e n α ), 0 < α < 1. This property does not hold for pMOM priors. To better demonstrate practical importance of these properties, we performed 20 simulation studies where the number of observations and covariates were n = 200 and p = 10, 000. The true model had size 6 with true coefficients equal to (0.5, 0.85, 1.00, 1.50, 1.85, 2.5). The sign of coefficients were chosen randomly with probability 0.5 in each simulation. The columns of the design matrix were multivariate Gaussian random variables with mean 0 and marginal variance of 1. The correlation between every two variables was 0.5. In each of the simulations, we fixed r = 1 and assigned τ 15 different values in the interval [0.01, 10]. The survival times were simulated from an exponential distribution with mean 10.
The proposed variable selection algorithm, was performed on the simulation data using both pMOM and piMOM priors. Table 2 summarizes the outcome of the selection procedure using different hyperparameter values for both priors. The numbers are averaged over 20 simulations. In that table, MTPR is the mean true positive rate, MFPR is the mean false positive rate and TMP is the proportion of times that the true model was found without any false positives.
As shown in Table 2 , the pMOM model never finds the true model for any of the τ values. Moreover, the average true positive rate for pMOM is always 5 times less than that for piMOM, and the average false positive rate for pMOM is higher than it is for piMOM. This suggests variable selection based on piMOM priors in ultrahigh dimensional settings is likely to perform better than variable selection based on pMOM priors.
Real Data
We studied two cancer genomic datasets provided by TCGA; KIRC (Cancer Genome Atlas Research Network, 2013) and KIRP (Cancer Genome Atlas Research Network, 2016) . We included patient's 'Age', 'Gender' and a clinical stage variable, 'Stage', in the design matrix. On the advice of a clinician, the 'Stage' variable has 3 levels and was developed by combining the histological stage, pathological stage, etc. into one variable that is representative of how advanced each subject's cancer was when tissue samples were taken. In the following, 'Stage i' represents the i th class of that variable; 'Stage 3' represents the most advanced stage. To remove stromal contaminations from the gene expression data, the DeMixT algorithm (Wang et al., 2017) , was performed on the design matrix and the tumor-specific expression data was used in the analyses for all algorithms. We compared our method to ISIS-SCAD, GLMNET and Stability Selection (Meinshausen and Bühlmann, 2010) . Stability Selection is combined with a high dimensional selection algorithm such as glmnet and selects the most stable features for a given Type I error level.
Predictive performance was measured by the time dependent AUC, as discussed in Section 2.5, based on a five-fold cross validation. The observations in each fold were randomly chosen under a constraint which balanced censoring rate between folds. The AUC values were computed for the test set using the model that was obtained by performing variable selection process on the training set. The selected genes for each cancer type were also compared. For our method, we report the genes associated with the highest posterior probability model. The hyperparameter τ of the piMOM prior was selected using the algorithm in Section 2.3.1 with α = 0.1 as the maximum of the piMOM prior. This is our choice of α for real datasets. In simulation data analyses, α was chosen to be 0.8 since the magnitude of non-zero coefficients in the dataset designed by Fan and Li (2002) were unrealistically large. The results for each cancer type are discussed in separate sections below. Note that GLMNET has a random output when the hyperparameter is selected by cross-validation. As a result, based on the recommendation of the inventors of that algorithm, we ran it 100 times for each fold and took the average of results as the outcome for that fold.
We note that we treated 'Stage' as a fixed covariate in our model. However, available ISIS-SCAD and Stability Selection software packages are not able to fix pre-selected covariates to include in all models. For this reason, each level of 'Stage' was coded as a binary variable in the design matrix and not fixed in the final model for those procedures.
To run the Stability Selection method, we used the c060 R package (Sill et al., 2014) and the recommended values for function arguments.
Kidney Renal Clear Cell Carcinoma (KIRC)
The KIRC dataset (Cancer Genome Atlas Research Network, 2013) contains 490 observations with 13,267 genes, after removing genes with missing expressions and observations with missing survival times. The censoring rate for this dataset is 66.94%. Table 3 shows the genes selected by each method. As mentioned previously, GLMNET produces random outputs at each run and therefore for the this table, only the output for one of the runs are indicated; other runs produced a similar number of selected genes.
In addition to the categorical variable 'Stage', BVSNLP selects 'AR' and 'SUDS3' as the most significant covariates in the design matrix. The posterior inclusion probabilities for 'Stage', 'AR' and 'SUDS3' are 1, 0.91 and 0.07, respectively. The MAP estimates for the coefficients of 'Stage 2', 'Stage 3', 'AR' and 'SUDS3' are 0.51, 1.58, −0.62 and 0.32, respectively. These coefficients indicate that the most advanced stage of cancer has the worst impact on the survival rate and a Stage 3 cancer patient hazard rate is 5 times higher than a Stage 1 cancer patient when all other covariates are equal. On the other hand, the negative sign for the 'AR' gene indicates it has a favorable impact on survival rate for KIRC. 'AR', the Androgen Receptor gene, functions as a steroid-hormone activated transcription factor. It has been well documented that 'AR' promotes the progression of renal cell carcinoma (RCC) through hypoxia-inducible factors HIF-2α and vascular endothelial growth factor regulation (Fenner, 2016) . The favorable impact of the 'AR' gene was also studied by Hata et al. (2017) in bladder cancer. 'SUDS3' is a regulatory protein that is part of the SIN3A corepressor complex component that potentially has a role in tumor suppressor pathways through regulation of apoptosis. There was previous evidence of the down-regulation of the SIN3A gene in lung cancer (Suzuki et al., 2008) .
It is noteworthy that the algorithm selected the same highest posterior probability model for different values of the hyperparameter τ in the range [0.01, 0.9], where there was no constraints on the modes of the piMOM prior. This shows the robustness of the proposed variable selection algorithm to the choice of hyperparameter τ for reasonable values.
For this particular run of GLMNET, a much larger model were selected with 24 variables including two of the variables reported by BVSNLP. ISIS-SCAD selected 13 genes, which included the 4 genes that were selected by the Stability Selection method. 'AR' and the last level of 'Stage' are the common genes among all methods. The time dependent AUC plot for all four methods, obtained by performing a five-fold cross validation, is depicted in Figure 2 .
As illustrated in Figure 2 , BVSNLP has very similar predictive accuracy to GLMNET and Stability Selection, but with a much sparser model. We investigated the genes that were selected by each of those algorithms in all five folds and found out that BVSNLP selects only 8 unique covariates in total, where 'Stage' and 'AR' are selected in all folds. In other words, two out of three genes that are selected using the full data were selected in all five training datasets in cross validation. The average run-time of our method, BVSNLP, for each fold was about 6.1 minutes using 120 CPUs.
GLMNET selected 160 different covariates across all 5 folds. Only five out of 24 selected genes in Table 3 , when using full data, were selected in all five training datasets, including 'Age', 'Stage' and 'AR'. GLMNET was run 100 times for each fold; the average run-time of this algorithm for each fold was about 3 hours on a single CPU. ISIS-SCAD selected 45 different covariates and only 'Stage 3' was selected in all training datasets in cross validation. The Stability Selection method selected sparser models compared to ISIS-SCAD and GLMNET by selecting 13 different covariates. It picked and only 'Age' and 'Stage 3' in all five folds. The average run-time of each fold for ISIS-SCAD and the Stability selection methods were 5.0 minutes on a single CPU and 1.3 minutes on 4 CPUs, respectively. Table 4 . In addition to the categorical variable 'Stage', BVSNLP selects the 'TPX2' gene as the most significant covariate in the design matrix. The posterior inclusion probabilities for 'Stage' and 'TPX2' were 1, 0.10, respectively. The MAP estimates for the coefficients of 'Stage 2', 'Stage 3' and 'TPX2' were 0.11, 0.70 and 1.06, respectively. This shows that a unit increase in 'TPX2' gene expression increases the hazard rate by a factor of 3, and the selected covariates all have an unfavorable impact on the survival rate. 'TPX2', microtubule nucleation factor, forms a regulatory circuitry with the tumor suppressor gene TP53 and is reportedly associated with cancer prognosis in various cancer types due to its central role for mitosis and spindle assembly (Neumayer et al., 2014) . Surprisingly, GLMNET does not select any genes and ISIS-SCAD selects covariates that are not common with BVSNLP. Stability Selection picked 3 covariates, with only 'Stage 3' in common with BVSNLP. Similarly to the previous dataset, we tested BVSNLP for different choices of τ in the [0.01, 0.9] interval and the same model was selected for all values within this range. The total run-time of BVSNLP for this dataset was around 5 minutes using 120 CPUs. Figure 3 shows the predictive accuracy for the proposed method based on a five-fold cross-validation. The outcomes for GLMNET, ISIS-SCAD and Stability Selection are not displayed in the plot because those methods did not converge or failed to produce results for at least one of the five folds in the cross-validation experiment. Regarding lower values of AUC plot for t < 1 year, note that according to Blanche et al. (2018) , a misspecified model could misleadingly result in higher values for other measures of predictive accuracy such as Harrell's c-index. This is not the case for the time dependent AUC, which is assumption free. This makes AUC a preferred choice for predictive accuracy measurement, but potentially causes AUC to have low values, even close to a 50% benchmark.
Discussion
In this article a Bayesian variable selection method, BVSNLP, was proposed for selecting variables in high and ultrahigh dimensional datasets with survival time outcomes. BVSNLP uses an inverse moment nonlocal prior density on non-zero regression coefficients. Analyses of simulated and real data suggest that BVSNLP performs comparably or better than other existing methods for variable selection for survival data. Moreover, the real data results indicated that the proposed algorithm is robust to the choice of hyperparameter τ of the piMOM prior for the values of τ in the range [0.01, 0.9]. Various outputs are provided by the algorithm. These include the HPPM, MPM and the posterior inclusion probability for each covariate in the model. For real datasets, Bayesian model averaging is used to incorporate uncertainty in selected models in computing time dependent AUC plots using Uno's method. Finally, an R package named BVSNLP has been implemented to make the algorithm available to interested researchers. The package can be run in parallel fashion where hundreds of CPUs can be exploited in order to increase the number of visited models in the search for highest posterior probability model. The BVSNLP package is available in the R repository, CRAN, at https://CRAN.R-project.org/package=BVSNLP. The user manual for the package is also available from this site.
Two real cancer genomic datasets from the TCGA website were considered in this article. Compared to other methods, BVSNLP found sparser models with biologically relevant genes. The proposed method showed a reliable predictive accuracy as measured by AUC using substantially fewer variables.
